Pulmonary arterial compliance and exercise capacity after pulmonary endarterectomy

European Respiratory Journal

Volumn 43, Issue 5, 2014, Pages 1403-1409

  Ghio, Stefano ^a   Morsolini, Marco ^a   Corsico, Angelo ^a   Klersy, Catherine ^a   Mattiucci, Gabriella ^a,b   Raineri, Claudia ^a   Scelsi, Laura ^a   Vistarini, Nicola ^a,b   Visconti, Luigi Oltrona ^a   D'Armini, Andrea Maria ^a,b  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE;

ADULT; ARTERIAL GAS; ARTERIAL OXYGEN TENSION; ARTERY COMPLIANCE; ARTICLE; CARBON MONOXIDE TRANSFER FACTOR; ECHOCARDIOGRAPHY; ENDARTERECTOMY; EXERCISE; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEART HEMODYNAMICS; HUMAN; LUNG COMPLIANCE; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PULMONARY ENDARTERECTOMY; RETROSPECTIVE STUDY; SPIROMETRY; SURVIVAL TIME; TREADMILL TEST; TRICUSPID ANNULAR PLANE EXCURSION; AGED; EXERCISE TEST; EXERCISE TOLERANCE; HEMODYNAMICS; HYPERTENSION, PULMONARY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PROCEDURES; PROGNOSIS; PULMONARY ARTERY; STATISTICAL MODEL; TIME; TREATMENT OUTCOME;

AGED; ENDARTERECTOMY; EXERCISE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FOLLOW-UP STUDIES; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; LUNG COMPLIANCE; MALE; MIDDLE AGED; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; PROGNOSIS; PULMONARY ARTERY; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84899890473     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00195313     Document Type: Article

References (24)

1. Moser KM, Bloor CM. Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest 1993; 103: 685-692.
2. Jamieson SW. Pulmonary thromboendarterectomy. Heart 1998; 79: 118-120.
3. Mayer E, Jenkins D, Lindner J, et al. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg 2011; 141: 702-710.
4. Madani MM, Auger WR, Pretorius V, et al. Pulmonary endarterectomy: recent changes in a single institution's experience of more than 2,700 patients. Ann Thorac Surg 2012; 94: 97-103.
5. Corsico AG, D'Armini AM, Cerveri I, et al. Long-term outcome after pulmonary endarterectomy. Am J Respir Crit Care Med 2008; 178: 419-424.
6. Lankhaar JW, Westerhof N, Faes TJ, et al. Quantification of right ventricular afterload in patients with and without pulmonary hypertension. Am J Physiol Heart Circ Physiol 2006; 291: H1731-H1737.
7. Lankhaar JW, Westerhof N, Faes TJ, et al. Pulmonary vascular resistance and compliance stay inversely related during treatment of pulmonary hypertension. Eur Heart J 2008; 29: 1688-1695.
8. Champion HC, Michelakis ED, Hassoun PM. Comprehensive invasive and noninvasive approach to the right ventricle pulmonary circulation unit: state of the art and clinical and research implications. Circulation 2009; 120: 992-1007.
9. Saouti N, Westerhof N, Helderman F, et al. Right ventricular oscillatory power is a constant fraction of total power irrespective of pulmonary artery pressure. Am J Respir Crit Care Med 2010; 182: 1315-1320.
10. Tedford RJ, Hassoun PM, Mathai SC, et al. Pulmonary capillary wedge pressure augments right ventricular pulsatile loading. Circulation 2012; 125: 289-297.
11. Bonderman D, Martischnig AM, Vonbank K, et al. Right ventricular load at exercise is a cause of persistent exercise limitation in patients with normal resting pulmonary vascular resistance after pulmonary endarterectomy. Chest 2011; 139: 122-127.
12. Morsolini M, Nicolardi S, Milanesi E, et al. Evolving surgical techniques for pulmonary endarterectomy according to the changing features of chronic thromboembolic pulmonary hypertension patients during 17-year single center experience. J Thorac Cardiovasc Surg 2012; 144: 100-107.
13. D'Armini AM, Zanotti G, Ghio S, et al. Reverse right ventricular remodeling after pulmonary endarterectomy. J Thorac Cardiovasc Surg 2007; 133: 162-168.
14. MacKenzie Ross RV, Toshner MR, Soon E, et al. Decreased time constant of the pulmonary circulation in chronic thromboembolic pulmonary hypertension. Am J Physiol Heart Circ Physiol 2013; 305: H259-H264.
15. Jaïs X, D'Armini AM, Jansa P, et al. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am Coll Cardiol 2008; 52: 2127-2134.
16. Delcroix M. Chronic post-embolic pulmonary hypertension: a new target for medical therapies? Eur Respir Rev 2013; 22: 258-264.
17. Bauer R, Dehnert C, Schoene P, et al. Skeletal muscle dysfunction in patients with idiopathic pulmonary arterial hypertension. Respir Med 2007; 101: 2366-2369.
18. Moser KM, Auger WR, Fedullo PF, et al. Chronic thromboembolic pulmonary hypertension: clinical picture and surgical treatment. Eur Respir J 1992; 5: 334-342.
19. Wranne B, Pinto FJ, Hammarström E, et al. Abnormal right heart filling after cardiac surgery: time course and mechanisms. Br Heart J 1991; 66: 435-442.
20. Nomura T, Lebowitz L, Koide Y, et al. Evaluation of hepatic venous flow using transesophageal echocardiography in coronary artery bypass surgery: an index of right ventricular function. J Cardiothorac Vasc Anesth 1995; 9: 9-17.
21. Benza RL, Miller DP, Gomberg-Maitland M, et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation 2010; 122: 164-172.
22. Humbert M, Sitbon O, Chaouat A, et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 2010; 122: 156-163.
23. Nickel N, Golpon H, Greer M, et al. The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension. Eur Respir J 2012; 39: 589-596.
24. Gabler NB, French B, Strom BL, et al. Validation of 6-minute walk distance as a surrogate end point in pulmonary arterial hypertension trials. Circulation 2012; 126: 349-356.